Humimab-HC 40 Injection consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

FAQs

How does Humimab-HC 40 Injection work?

Humimab-HC 40 Injection contains Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive.

Who should not take Humimab-HC 40 Injection ?

Humimab-HC 40 Injection affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis or abnormal liver enzymes. Humimab-HC 40 Injection can also increase the risk of developing cancers; hence, informing your doctor if you have a history of any cancer is essential.